Equities

Accolade Inc

Accolade Inc

Actions
  • Price (USD)7.89
  • Today's Change-1.30 / -14.15%
  • Shares traded1.49m
  • 1 Year change-50.69%
  • Beta2.1352
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.

  • Revenue in USD (TTM)388.49m
  • Net income in USD-122.73m
  • Incorporated2007
  • Employees2.37k
  • Location
    Accolade Inc660 W. Germantown Pike Suite 500PLYMOUTH MEETING 19462United StatesUSA
  • Phone+1 (610) 834-2989
  • Fax+1 (302) 636-5454
  • Websitehttps://www.accolade.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ModivCare Inc2.75bn-204.46m334.51m21.20k--2.14--0.1216-14.43-14.43194.0711.001.48--8.33129,772.20-11.03-1.36-15.17-1.8316.2517.58-7.44-0.9619--0.55150.8754--9.8514.71-542.83--19.27--
DocGo Inc624.29m6.86m376.06m2.92k60.661.2514.200.60240.05950.05955.902.891.41--3.42214,164.202.27--3.33--31.30--1.61------0.1068--41.72---80.17------
CareDx Inc280.32m-190.28m391.45m635.00--1.49--1.40-3.55-3.555.215.070.55525.274.78441,455.10-37.69-17.54-44.47-20.8563.6165.50-67.88-27.783.77--0.00---12.8929.63-148.37--5.01--
Aveanna Healthcare Holdings Inc1.90bn-134.52m423.23m3.50k------0.2233-0.7105-0.71059.99-0.66811.14--8.04541,488.30-8.09---10.18--31.4231.12-7.10-12.71--1.471.10--6.028.6279.68---20.76--
Sonida Senior Living Inc255.32m-26.10m434.15m2.62k----31.491.70-3.57-3.5736.69-8.140.3981--36.1497,562.86-3.29-6.63-3.88-8.19-----8.27-18.04---0.50651.12--7.08-11.1155.74---3.97--
QDM International Inc6.53m1.69m466.21m3.0042.02143.15272.0671.360.0380.0380.02960.01121.81--148.49--46.82--127.17--38.10--25.81----1,761.140.2722--1,542.96--111.78------
Community Health Systems Inc12.52bn-123.00m471.15m61.00k----0.90780.0376-0.9399-0.939995.71-10.280.86255.865.91205,295.100.20660.75660.25460.938184.2483.690.23960.93451.331.211.08--2.28-2.47-389.13---2.39--
Enhabit Inc1.05bn-80.50m502.80m10.80k--0.7496--0.4806-1.62-1.6220.9313.380.7069--6.6696,879.63-5.34---6.02--48.81---7.55----0.62790.4406---2.32---99.26------
Talkspace Inc150.05m-19.18m526.98m472.00--4.43--3.51-0.1171-0.11710.90930.70441.01--15.15317,891.90-12.85---15.38--49.57---12.78------0.00--25.49--75.92------
InnovAge Holding Corp720.80m-31.56m531.37m2.10k--1.86--0.7372-0.2326-0.23265.312.101.33--17.56343,236.20-6.31---8.38--16.48---4.73-----4.190.2146---1.51---523.72------
Diversified Healthcare Trust1.41bn-293.57m584.22m0.00--0.2553.250.4143-1.23-1.235.909.720.2464--190.62---4.77-1.04-4.82-1.0616.7524.43-19.37-4.93---0.44050.5466--9.874.77-1,761.11--0.1461-51.94
Accolade Inc388.49m-122.73m610.75m2.37k--1.40--1.57-1.65-1.655.225.650.4572--15.62163,918.10-14.45-31.21-16.73-37.4944.8144.36-31.59-69.22----0.3238--17.1336.43-273.32--0.2088--
Pennant Group Inc544.89m13.38m631.53m5.79k46.914.4333.171.160.44290.442918.054.691.04--9.5194,092.732.641.813.092.1420.1021.622.551.92--3.940.30520.0015.1413.76101.40-3.1314.07--
Pediatrix Medical Group Inc1.99bn-60.41m759.59m2.90k--0.8945--0.3808-0.7353-0.735324.1510.110.8734--7.01687,806.90-2.650.8579-3.220.9945-----3.031.52--4.420.42720.001.152.97-196.55--14.25--
Data as of Apr 26 2024. Currency figures normalised to Accolade Inc's reporting currency: US Dollar USD

Institutional shareholders

50.91%Per cent of shares held by top holders
HolderShares% Held
Brown Advisory LLCas of 31 Mar 20245.85m7.55%
ARK Investment Management LLCas of 31 Mar 20245.61m7.25%
The Vanguard Group, Inc.as of 31 Dec 20235.14m6.65%
BlackRock Fund Advisorsas of 31 Dec 20234.89m6.32%
Bellevue Asset Management AGas of 31 Dec 20234.51m5.82%
JPMorgan Investment Management, Inc.as of 31 Dec 20233.59m4.64%
Rock Springs Capital Management LPas of 31 Dec 20233.49m4.50%
JPMorgan Asset Management (UK) Ltd.as of 31 Dec 20232.60m3.36%
Dimensional Fund Advisors LPas of 31 Dec 20231.92m2.48%
Nikko Asset Management Americas, Inc.as of 31 Dec 20231.80m2.33%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.